51. 全身性強皮症 Scleroderma Clinical trials / Disease details

臨床試験数 : 525 / 薬物数 : 565 - (DrugBank : 148) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 217

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-005116-21-PL (EUCTR)	27/09/2021	25/06/2021	FT011 for Scleroderma	A phase II, randomised, double blind, placebo-controlled study of the pharmacokinetics, pharmacodyna ...	diffuse systemic sclerosis MedDRA version: 21.0;Level: LLT;Classification code 10012977;Term: Diffus ...	Product Name: FT011 100 mg Product Code: FT011 INN or Proposed INN: None yet Other descriptive name: 2-(( ...	Certa Therapeutics Pty Ltd	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	30	Phase 2	Spain;Poland;Ukraine;Australia;Russian Federation;Netherlands
2	EUCTR2020-005116-21-ES (EUCTR)	22/07/2021	22/07/2021	FT011 for Scleroderma	A phase II, randomised, double blind, placebo-controlled study of the pharmacokinetics, pharmacodyna ...	diffuse systemic sclerosis MedDRA version: 21.0;Level: LLT;Classification code 10012977;Term: Diffus ...	Product Name: FT011 100 mg Product Code: FT011 INN or Proposed INN: None yet Other descriptive name: 2-(( ...	Certa Therapeutics Pty Ltd	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	30	Phase 2	Poland;Spain;Ukraine;Australia;Russian Federation;Netherlands

First Previous1Next Last